Cepacol Lozenge
NDC Package 17856-0732-1
Package Information
Cepacol (benzocaine and menthol) lozenges is adults and children 5 years of age and older: allow one lozenge to dissolve slowly in the mouth; may be repeated every 2 hours as needed or as directed by a doctor or dentist.children under 5 years of age: do not use. This formulation utilizes a lozenge delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0732 and is authorized under FDA application M.
Identification & Billing
- RxCUI: 1235472 - Cepacol Sore Throat 15 MG / 2.6 MG Oral Lozenge
- RxCUI: 1235472 - benzocaine 15 MG / menthol 2.6 MG Oral Lozenge [Cepacol Sore Throat Pain Relief]
- RxCUI: 1235472 - Cepacol Sore Throat Pain Relief 15/2.6 (benzocaine / menthol) Oral Lozenge
- RxCUI: 1235472 - Cepacol Sore Throat Pain Relief 15/2.6 Oral Lozenge
- RxCUI: 858664 - benzocaine 15 MG / menthol 2.6 MG Oral Lozenge
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-0732 - Cepacol
- 17856-0732-1 - 50 POUCH in 1 BOX / 1 LOZENGE in 1 POUCH (17856-0732-2)
- 17856-0732 - Cepacol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-0732-1 identifies a specific commercial package of 50 pouch in 1 box / 1 lozenge in 1 pouch (17856-0732-2) of Cepacol Extra Strength Sore Throat Honey Lemon, a human over the counter drug labeled by Atlantic Biologicals Corp.. This product is billed for "EA" each discreet unit and contains an estimated amount of 50 billable units per package. This lozenge is formulated for oral use and contains benzocaine; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on July 15, 2013. The current certification is valid through December 31, 2026.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856073201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 50 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.